Literature DB >> 23711693

Intentional coverage of the celiac artery during thoracic endovascular aortic repair.

Jeffrey Jim1, Francis J Caputo, Luis A Sanchez.   

Abstract

Intentional coverage of the celiac artery (CA) can extend the distal landing zone necessary for thoracic endovascular aortic repair. A comprehensive review identified 93 cases in 17 reports describing this technique. The majority (87%) were elective procedures. Prior to endograft deployment, 21 patients underwent CA embolization. Of the remaining, three developed type II endoleaks from the CA requiring treatment. The superior mesenteric artery (SMA) was stented in 18 patients during the operative procedure, with one patient undergoing delayed stent placement. There were five iliac artery injuries but no other intraoperative complications. The 30-day mortality rate was 9.7% with three cases attributed to foregut ischemia. Overall, this procedure is technically safe but is associated with a significant risk of death and morbidity. Furthermore, durability is unclear as long-term data are lacking. Careful patient selection, preoperative determination of adequate CA-SMA collaterals, and demonstration of postprocedure SMA patency are all mandatory components of this procedure. However, the development of foregut ischemia cannot be reliably predicted, and patients should be monitored closely for this unique postoperative complication.
Copyright © 2013 Society for Vascular Surgery. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23711693     DOI: 10.1016/j.jvs.2013.04.003

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  6 in total

1.  Thoracic stent graft with distal fenestration for the superior mesenteric artery for treatment of thoracic aortic aneurysm.

Authors:  Ryota Fukunaga; Takuya Matsumoto; Yukihiko Aoyagi; Daisuke Matsuda; Shinichi Tanaka; Jun Okadome; Koichi Morisaki; Yoshihiko Maehara
Journal:  Ann Vasc Dis       Date:  2014-03-31

2.  Mid-term results of endovascular treatment with the Gore TAG device for degenerative descending thoracic aortic aneurysms.

Authors:  Junji Yunoki; Toru Kuratani; Yukitoshi Shirakawa; Kei Torikai; Kazuo Shimamura; Keiwa Kin; Yoshiki Sawa
Journal:  Gen Thorac Cardiovasc Surg       Date:  2014-06-17

3.  Occlusion of the Celiac Artery during Endovascular Thoracoabdominal Aortic Aneurysm Repair Is associated with Increased Perioperative Morbidity and Mortality.

Authors:  Ryan W King; Ryan Gedney; Jean Marie Ruddy; Elizabeth A Genovese; Thomas E Brothers; Ravi K Veeraswamy; Mathew D Wooster
Journal:  Ann Vasc Surg       Date:  2020-02-05       Impact factor: 1.466

4.  Acute pancreatitis caused by pancreatic ischemia after TEVAR combined with intentional celiac artery coverage and embolization of the branches of the celiac artery.

Authors:  Yohei Kawatani; Hirotsugu Kurobe; Yoshitsugu Nakamura; Yuji Suda; Yoshinori Okuma; Shinichiro Sato; Toru Hashimoto; Takaki Hori
Journal:  J Surg Case Rep       Date:  2017-02-23

5.  Extensive Organ Necrosis After Thoracic Endovascular Aortic Repair for Thoracic Aortic Aneurysm: A Report of the Usefulness of Laparoscopic Indocyanine Green Intraoperative Blood Flow Assessment.

Authors:  Shoryu Takayama; Ken Ishikawa; Hisanori Kani; Satoru Takayama; Masaki Sakamoto
Journal:  Cureus       Date:  2022-02-13

Review 6.  Peri-Operative Management of Patients Undergoing Fenestrated-Branched Endovascular Repair for Juxtarenal, Pararenal and Thoracoabdominal Aortic Aneurysms: Preventing, Recognizing and Treating Complications to Improve Clinical Outcomes.

Authors:  Andrea Xodo; Mario D'Oria; Bernardo Mendes; Luca Bertoglio; Kevin Mani; Mauro Gargiulo; Jacob Budtz-Lilly; Michele Antonello; Gian Franco Veraldi; Fabio Pilon; Domenico Milite; Cristiano Calvagna; Filippo Griselli; Jacopo Taglialavoro; Silvia Bassini; Anders Wanhainen; David Lindstrom; Enrico Gallitto; Luca Mezzetto; Davide Mastrorilli; Sandro Lepidi; Randall DeMartino
Journal:  J Pers Med       Date:  2022-06-21
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.